SARS-COV-2 (COVID-19) IGM/IGG AB RAPID TEST

Specimen:

  • Whole Blood/Serum/Plasma

  • Format: Cassette

Product Features:

The SARS-CoV-2 IgM/IgG Ab Rapid Test is used to detect the IgM and IgG antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human serum, plasma or whole blood sample qualitatively. It it to be used as an aid in the diagnosis of coronavirus infection disease (COVID-19), which is caused by SARS-CoV-2.

 

The test provides preliminary test results. Negative results don't preclude SARS-CoV-2 infection and they cannot be used as the sole basis for treatment or other management decision.

 

 

COVID-19, it is a novel coronavirus with new strain thathas not been previously identified in humans, belongs to Coronaviruses (CoV) suchas Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome(SARS-CoV).

Kit Size:

40T/box, 48 boxes/ctn

Specification:

  • Fast Reaction: 15 minutes

  • IgM Sensitivity: 82%

  • IgM Specificity: 97%

  • IgG Sensitivity: 93%

  • IgG Specificity: 97.5%

  • Positive Coincident Rate: ≥82%

  • Negative Coincident Rate: ≥96%

    Note: Results compared to molescular tersting.

  • Facebook - Black Circle
  • Instagram - Black Circle
  • YouTube - Black Circle
© 2019 Genopharma Sdn Bhd. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Genopharma, its subsidiaries or affiliates. No use of any Genopharma trademark, trade name, or trade dress in this site may be made without the prior written authorization of Genopharma, except to identify the product or services of the company.